2.32 USD
-0.42 (-15.33%)
2.31 USD
-0.01 (-0.43%)
XAGE gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. XAGE has a bad profitability rating. Also its financial health evaluation is rather negative. XAGE has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year XAGE has reported negative net income.
- XAGE had a negative operating cash flow in the past year.
- In the past 5 years XAGE reported 4 times negative net income.
- In the past 5 years XAGE always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -193.18%, XAGE is doing worse than 90.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -193.18% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-242.83%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- XAGE has a Gross Margin of 57.46%. This is in the better half of the industry: XAGE outperforms 77.26% of its industry peers.
- XAGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 57.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- XAGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- XAGE has less shares outstanding than it did 1 year ago.
- The debt/assets ratio for XAGE is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -32.91, we must say that XAGE is in the distress zone and has some risk of bankruptcy.
- XAGE's Altman-Z score of -32.91 is on the low side compared to the rest of the industry. XAGE is outperformed by 90.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -32.91 |
ROIC/WACCN/A
WACC9.31%
2.3 Liquidity
- A Current Ratio of 0.47 indicates that XAGE may have some problems paying its short term obligations.
- XAGE has a Current ratio of 0.47. This is amonst the worse of the industry: XAGE underperforms 93.53% of its industry peers.
- XAGE has a Quick Ratio of 0.47. This is a bad value and indicates that XAGE is not financially healthy enough and could expect problems in meeting its short term obligations.
- XAGE has a Quick ratio of 0.30. This is amonst the worse of the industry: XAGE underperforms 94.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
- XAGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.55%, which is quite impressive.
- XAGE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -71.88%.
EPS 1Y (TTM)66.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.38%
Revenue 1Y (TTM)-71.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3994.31%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for XAGE. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- XAGE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LONGEVITY HEALTH HOLDINGS IN / XAGE FAQ
What is the ChartMill fundamental rating of LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?
ChartMill assigns a fundamental rating of 0 / 10 to XAGE.
What is the valuation status for XAGE stock?
ChartMill assigns a valuation rating of 0 / 10 to LONGEVITY HEALTH HOLDINGS IN (XAGE). This can be considered as Overvalued.
Can you provide the profitability details for LONGEVITY HEALTH HOLDINGS IN?
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a profitability rating of 1 / 10.